Skip to main content

Table 3 Demographic and clinical data for all ELSO registry patients, ELSO registry patients excluding patients from Children's Healthcare of Atlanta at Egleston, and Children's at Egleston patients alone

From: Experience with use of extracorporeal life support for severe refractory status asthmaticus in children

 

All patients (n = 64) median

(range)

ELSO alone (n = 51) median

(range)

Children's at Egleston (n = 13) median

(range)

Age (years)

10

(1 to 17)

10

(1 to 17)

10

(1 to17)

Hours on ECLS (hours)

93

(31 to 395)

91

(31 to 218)

97.5

(42 to 395)

Survival (%)

60/64 (95%)

47/51 (92%)

13/13 (100%)

PEEP (cmH2O)

5

(0 to 20)

5

(0 to 20)

5

(0 to 15)

PIP (cmH2O)

44

(23 to 130)

42

(23 to 130)

51

(40 to 80)

MAP (cmH2O)

15

(3 to 48)

16

(3 to 48)

19

(9 to 24)

Cardiorespiratory arrest prior to ECLS (%)

9/64 (14%)

5/51 (10%)

4/13 (31%)

pH

6.98

(6.75 to 7.28)

6.98

(6.78 to 7.28)

6.89

(6.75 to 7.03)

PaCO2 (mmHg)

122

(61 to 284)

121

(61 to 284)

130

(102 to 186)

Percentage VV cannulation use

86%

82%

92%

  1. No significant differences were noted between group variables.
  2. ECLS = extracorporeal life support; ELSO = Extracorporeal Life Support Organization; MAC = minimum alveolar concentration; PaCO2 = partial pressure of arterial carbon dioxide; PEEP = peak end expiratory pressure; PIP = peak inspiratory pressure; VV = venovenous.